Summary Of Significant Accounting Policies (Tables)

3 Months Ended

Sep. 30, 2021

Summary Of Significant Accounting Policies [Abstract]

Summary Of Net Revenue Disaggregated By Product And Region

	Three Months Ended ‎September 30,
	2021		2020
U.S., Canada and Latin America
Devices	$	275,932	$	197,393
Masks and other		215,106		205,760
Total Sleep and Respiratory Care	$	491,038	$	403,153
Software as a Service		97,516		92,143
Total	$	588,554	$	495,296
Combined Europe, Asia and other markets
Devices	$	218,226	$	176,026
Masks and other		97,235		80,622
Total Sleep and Respiratory Care	$	315,461	$	256,648
Global revenue
Devices	$	494,158	$	373,419
Masks and other		312,341		286,382
Total Sleep and Respiratory Care	$	806,499	$	659,801
Software as a Service		97,516		92,143
Total	$	904,015	$	751,944

Summary Of Contract Balances

	September 30, ‎2021		June 30, ‎2021		Balance sheet caption
Contract assets
Accounts receivable, net	$	575,554	$	614,292	Accounts receivable, net
Unbilled revenue, current		25,799		10,893	Prepaid expenses and other current assets
Unbilled revenue, non-current		7,267		6,214	Prepaid taxes and other non-current assets
Contract liabilities
Deferred revenue, current		(112,528)		(109,611)	Deferred revenue (current liabilities)
Deferred revenue, non-current		(93,255)		(91,496)	Deferred revenue (non-current liabilities)

Schedule Of Components Of Lease Revenue

	Three Months Ended ‎September 30,
	2021		2020
Sales-type lease revenue	$	4,087	$	1,960
Operating lease revenue		25,157		24,779
Total lease revenue	$	29,244	$	26,739